Daniel Teper News Today

Press Release Crossject engages Syneos Health for U.S. commercial launch of ZEPIZURE®  Crossject expanding market access activities in preparation for filing for marketing...

Press ReleaseCrossject engages Syneos Health for U.S. commercial launch of ZEPIZURE®Crossject expanding market access activities in preparation f...

While the local robo-advice industry flounders, Wealthfront has hit a record high of more than US$50 billion ($77bn) in assets under management, catering to 700,000 investors.

SARASOTA, Fla. and AVENTURA, Fla., Nov. 10, 2023 /PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq: INVO ) ("INVO"), a healthcare services company focused on expanding access to advanced fertility treatment worldwide,

SARASOTA, Fla. and AVENTURA, Fla., Nov. 10, 2023 /PRNewswire/ -- INVO Bioscience, Inc. , a healthcare services company focused on expanding access to advanced fertility treatment worldwide, and...

The past year has been challenging for the Australian fintech sector with both total investment and the number of deals materially dropping compared to the previous year.

Post-merger, the combined company, operating under the name NAYA Biosciences, will be dedicated to increasing patient access to life-transforming treatments in oncology, fertility, and regenerative...

Shares of INVO Bioscience, Inc. (INVO) surged on a deal to buy NAYA Biosciences in an all-stock deal. INVO is currently trading at $2.8400, up $2.3000 or 425.

NAYA Biosciences entered into an agreement to acquire INVO Bioscience, Inc. in a reverse merger transaction for $9.8 million on October 23, 2023. Under the terms of the agreement, NAYA Biosciences...

Breaking Stock News - INVO Bioscience (NASDAQ: INVO) and NAYA Biosciences Announce Definitive Merger Agreement To Establish Expanded Publicly Traded Life Science Company